Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 17 studies | 44% ± 26% | |
smooth muscle cell | 16 studies | 32% ± 13% | |
basal cell | 16 studies | 45% ± 19% | |
pericyte | 14 studies | 32% ± 16% | |
conventional dendritic cell | 11 studies | 22% ± 7% | |
fibroblast | 11 studies | 25% ± 11% | |
mast cell | 10 studies | 20% ± 3% | |
secretory cell | 9 studies | 54% ± 29% | |
type II pneumocyte | 6 studies | 23% ± 9% | |
club cell | 6 studies | 33% ± 16% | |
goblet cell | 6 studies | 35% ± 21% | |
abnormal cell | 5 studies | 27% ± 5% | |
monocyte | 4 studies | 21% ± 3% | |
respiratory goblet cell | 4 studies | 24% ± 7% | |
classical monocyte | 4 studies | 19% ± 2% | |
macrophage | 4 studies | 20% ± 4% | |
ciliated cell | 4 studies | 41% ± 15% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 42% ± 11% | |
leukocyte | 4 studies | 21% ± 6% | |
duct epithelial cell | 3 studies | 22% ± 2% | |
extravillous trophoblast | 3 studies | 88% ± 7% | |
placental villous trophoblast | 3 studies | 93% ± 7% | |
myeloid cell | 3 studies | 27% ± 2% | |
enterocyte | 3 studies | 26% ± 1% | |
luminal cell of prostate epithelium | 3 studies | 75% ± 6% | |
dendritic cell | 3 studies | 27% ± 7% | |
keratinocyte | 3 studies | 55% ± 22% | |
progenitor cell of mammary luminal epithelium | 3 studies | 46% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 91% | 452.55 | 325 / 359 | 96% | 201.66 | 274 / 286 |
bladder | 95% | 465.81 | 20 / 21 | 90% | 112.80 | 456 / 504 |
lung | 96% | 325.91 | 555 / 578 | 88% | 103.27 | 1021 / 1155 |
skin | 100% | 740.04 | 1808 / 1809 | 81% | 111.77 | 384 / 472 |
prostate | 98% | 639.86 | 241 / 245 | 81% | 51.59 | 407 / 502 |
uterus | 92% | 178.94 | 157 / 170 | 86% | 101.03 | 395 / 459 |
esophagus | 74% | 571.80 | 1075 / 1445 | 98% | 225.49 | 180 / 183 |
intestine | 75% | 316.18 | 728 / 966 | 97% | 192.97 | 511 / 527 |
thymus | 97% | 239.92 | 634 / 653 | 73% | 56.51 | 444 / 605 |
breast | 93% | 217.11 | 426 / 459 | 57% | 31.53 | 632 / 1118 |
pancreas | 48% | 76.52 | 159 / 328 | 89% | 151.54 | 159 / 178 |
ovary | 48% | 76.18 | 86 / 180 | 85% | 74.70 | 364 / 430 |
kidney | 98% | 427.91 | 87 / 89 | 21% | 7.67 | 186 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.95 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 96% | 85.46 | 43 / 45 |
adipose | 95% | 263.66 | 1143 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 297.42 | 1227 / 1335 | 0% | 0 | 0 / 0 |
liver | 39% | 123.97 | 88 / 226 | 40% | 26.15 | 163 / 406 |
adrenal gland | 70% | 97.48 | 180 / 258 | 9% | 7.24 | 21 / 230 |
spleen | 70% | 93.27 | 168 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 68% | 44.22 | 54 / 80 |
heart | 42% | 56.79 | 364 / 861 | 0% | 0 | 0 / 0 |
brain | 28% | 42.38 | 736 / 2642 | 7% | 3.11 | 47 / 705 |
peripheral blood | 19% | 26.81 | 177 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 3.12 | 3 / 29 |
muscle | 3% | 2.52 | 22 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070873 | Biological process | regulation of glycogen metabolic process |
GO_0006915 | Biological process | apoptotic process |
GO_0060721 | Biological process | regulation of spongiotrophoblast cell proliferation |
GO_0010468 | Biological process | regulation of gene expression |
GO_0045995 | Biological process | regulation of embryonic development |
GO_0030334 | Biological process | regulation of cell migration |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0001890 | Biological process | placenta development |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_1901981 | Molecular function | phosphatidylinositol phosphate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PHLDA2 |
Protein name | Pleckstrin homology-like domain family A member 2 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein) (Imprinted in placenta and liver protein) (Tumor-suppressing STF cDNA 3 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein) (p17-Beckwith-Wiedemann region 1 C) (p17-BWR1C) |
Synonyms | BWR1C TSSC3 HLDA2 IPL |
Description | FUNCTION: Plays a role in regulating placenta growth. May act via its PH domain that competes with other PH domain-containing proteins, thereby preventing their binding to membrane lipids (By similarity). . |
Accessions | ENST00000314222.5 ENST00000618418.2 Q53GA4 |